Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Alberta

$64,000.00

Molecular pathways maintaining homeostasis in the vertebrate muscle sarcomere

EF 2022-23

Résumé
Our lab studies the molecular pathways that control and effect cell determination and differentiation. Of particular interest are the mechanisms of quality control in the metazoan muscle sarcomere, overlapping myosin and actin filaments that are joined by other proteins that give strength and elasticity to the complex in three dimensions while allowing the dramatic contraction of the fibers. Even minor defects in the assembly or stability of these protein complexes can compromise their function. There are highly regulated pathways that control the abundance of nascent structural components, and a strict order in which components are added to the sarcomere. The most abundant protein components of muscle are well known, but little is understood about the factors that regulate assembly, maintain the functional contractile state, and repair or replace the contractile components as they denature or are damaged. These assembly' factors have been the recent focus of our lab towards two goals. (i) use genetics to uncover novel components of this pathway, and (ii) determine how these components regulate sarcomere patterning and assembly in skeletal and cardiac muscle, and test predictions of these models in vivo. The process of metazoan myogenesis is remarkably conserved, allowing us to extend our initial work in C. elegans to vertebrate muscle. The zebrafish is our experimental system of choice for the experiments described here, and recent developments in genome editing technology (CRISPR/Cas9) has made this system even more powerful. The first aim is to determine what role the non-structural quality control components (such as unc45b and smyd1b) play in patterning of sarcomeres, and to determine whether they work via ubiquitin-mediated protein degradation. This will monitor spatial and temporal expression of the components during early sarcomere assembly, and examine sarcomere structure in animals mutant for the major components. In the second aim, we will search for novel factors that work in this process, using existing muscle mutants (where the cognate gene is not identified) and analysis of transcript datasets derived from muscle mutants affecting different sarcomere assembly steps. In the last aim, we will use CRISPR/Cas9 to generate knockouts of suspected sarcomere assembly components for which mutants are not available (e.g. myomesin, and some E3 ligases). These mutants will be tested for abnormal sarcomere structure due to defects in assembly.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2018-06684
Name nom
Pilgrim, David
Department département
Biological Sciences - Biological Sciences
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5000
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Genetics
Research subject fr
Génétique
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
Molecular pathways maintaining homeostasis in the vertebrate muscle sarcomere
Application summary
Our lab studies the molecular pathways that control and effect cell determination and differentiation. Of particular interest are the mechanisms of quality control in the metazoan muscle sarcomere, overlapping myosin and actin filaments that are joined by other proteins that give strength and elasticity to the complex in three dimensions while allowing the dramatic contraction of the fibers. Even minor defects in the assembly or stability of these protein complexes can compromise their function. There are highly regulated pathways that control the abundance of nascent structural components, and a strict order in which components are added to the sarcomere. The most abundant protein components of muscle are well known, but little is understood about the factors that regulate assembly, maintain the functional contractile state, and repair or replace the contractile components as they denature or are damaged. These assembly' factors have been the recent focus of our lab towards two goals. (i) use genetics to uncover novel components of this pathway, and (ii) determine how these components regulate sarcomere patterning and assembly in skeletal and cardiac muscle, and test predictions of these models in vivo. The process of metazoan myogenesis is remarkably conserved, allowing us to extend our initial work in C. elegans to vertebrate muscle. The zebrafish is our experimental system of choice for the experiments described here, and recent developments in genome editing technology (CRISPR/Cas9) has made this system even more powerful. The first aim is to determine what role the non-structural quality control components (such as unc45b and smyd1b) play in patterning of sarcomeres, and to determine whether they work via ubiquitin-mediated protein degradation. This will monitor spatial and temporal expression of the components during early sarcomere assembly, and examine sarcomere structure in animals mutant for the major components. In the second aim, we will search for novel factors that work in this process, using existing muscle mutants (where the cognate gene is not identified) and analysis of transcript datasets derived from muscle mutants affecting different sarcomere assembly steps. In the last aim, we will use CRISPR/Cas9 to generate knockouts of suspected sarcomere assembly components for which mutants are not available (e.g. myomesin, and some E3 ligases). These mutants will be tested for abnormal sarcomere structure due to defects in assembly.